Immunovant
IMVT
IMVT
112 hedge funds and large institutions have $238M invested in Immunovant in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.15% more ownership
Funds ownership: 34.45% → 36.59% (+2.1%)
9% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 33
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
112
Holding in Top 10
1
Calls
$3.18M
Puts
$614K
Top Buyers
| 1 | +$11M | |
| 2 | +$9.33M | |
| 3 | +$4.53M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$2.26M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.67M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$2.73M | |
| 3 | -$1.63M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$1.62M |
| 5 |
Two Sigma Advisers
New York
|
-$1.11M |